CTO-话题@MedSci

#CTO#

80篇内容 | 3275人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1862796, encodeId=2efb1862e9696, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=宋光远：知难而进——CTO开通策略中球囊的应用, objectType=article, longId=206550, objectId=3400206550e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3400206550e4, replyNumber=0, likeNumber=102, createdTime=2021-07-23, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3400206550e4, moduleTitle=宋光远：知难而进——CTO开通策略中球囊的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3400206550e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862793, encodeId=17051862e9355, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病, objectType=article, longId=203528, objectId=9b0d20352851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0d20352851, replyNumber=0, likeNumber=87, createdTime=2021-09-18, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0d20352851, moduleTitle=Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0d20352851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862789, encodeId=d9711862e8994, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=NEJM：Vericiguat能减少心衰高危患者的死亡和住院风险（VICTORIA试验）, objectType=article, longId=191516, objectId=bdf019151683, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf019151683, replyNumber=0, likeNumber=71, createdTime=2021-01-03, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf019151683, moduleTitle=NEJM：Vericiguat能减少心衰高危患者的死亡和住院风险（VICTORIA试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf019151683)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862792, encodeId=143f1862e92de, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血, objectType=article, longId=196108, objectId=e997196108f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e997196108f4, replyNumber=0, likeNumber=108, createdTime=2021-02-07, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e997196108f4, moduleTitle=WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e997196108f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862790, encodeId=61bd1862e90a6, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Ann Rheum Dis：一种新型可靠的银屑病关节炎指炎整体超声评分(DACTOS), objectType=article, longId=194525, objectId=a9de194525b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9de194525b2, replyNumber=0, likeNumber=80, createdTime=2020-11-17, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9de194525b2, moduleTitle=Ann Rheum Dis：一种新型可靠的银屑病关节炎指炎整体超声评分(DACTOS), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9de194525b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862787, encodeId=ec401862e87b9, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Clinica Chimica Acta：α-Galactosidase / lysoGb3比作为诊断Fabry病女性的一个潜在的标记？, objectType=article, longId=187628, objectId=b66718e62899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b66718e62899, replyNumber=0, likeNumber=59, createdTime=2020-12-26, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b66718e62899, moduleTitle=Clinica Chimica Acta：α-Galactosidase / lysoGb3比作为诊断Fabry病女性的一个潜在的标记？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b66718e62899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862781, encodeId=ada91862e81d5, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, objectType=article, longId=168698, objectId=ca0c168698eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0c168698eb, replyNumber=0, likeNumber=58, createdTime=2019-11-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0c168698eb, moduleTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca0c168698eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862783, encodeId=620c1862e83b9, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现, objectType=article, longId=170144, objectId=32b91e014439, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b91e014439, replyNumber=0, likeNumber=73, createdTime=2020-01-07, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b91e014439, moduleTitle=开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b91e014439)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862788, encodeId=75cd1862e8869, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=信达生物与Alector合作在中国开发抗肿瘤的SIRP-α单抗, objectType=article, longId=190928, objectId=d3031909289d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3031909289d, replyNumber=0, likeNumber=67, createdTime=2020-09-10, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3031909289d, moduleTitle=信达生物与Alector合作在中国开发抗肿瘤的SIRP-α单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3031909289d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862779, encodeId=e7b31862e79e4, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=解决复杂CTO难题：IVUS-ATS技术具有重要补充价值, objectType=article, longId=167039, objectId=22a116e039a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22a116e039a4, replyNumber=0, likeNumber=69, createdTime=2019-11-29, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22a116e039a4, moduleTitle=解决复杂CTO难题：IVUS-ATS技术具有重要补充价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22a116e039a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862782, encodeId=64801862e82c2, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=FDA批准Novo Nordisk的Victoza治疗2型糖尿病儿童患者, objectType=article, longId=168713, objectId=ec97168e1391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec97168e1391, replyNumber=0, likeNumber=75, createdTime=2019-12-13, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec97168e1391, moduleTitle=FDA批准Novo Nordisk的Victoza治疗2型糖尿病儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec97168e1391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862778, encodeId=fca01862e7836, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Biofactors：研究发现Zg有益于治疗骨和骨相关疾病, objectType=article, longId=166826, objectId=38371668262e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38371668262e, replyNumber=0, likeNumber=84, createdTime=2019-12-12, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38371668262e, moduleTitle=Biofactors：研究发现Zg有益于治疗骨和骨相关疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38371668262e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862786, encodeId=87df1862e86d0, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=CTOCC 2019｜《冠状动脉慢性完全闭塞病变介入治疗——策略、技术和病例精选》重磅发布, objectType=article, longId=182766, objectId=8583182e6602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8583182e6602, replyNumber=0, likeNumber=120, createdTime=2020-04-14, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8583182e6602, moduleTitle=CTOCC 2019｜《冠状动脉慢性完全闭塞病变介入治疗——策略、技术和病例精选》重磅发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8583182e6602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862784, encodeId=bf921862e845a, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=CTONG着眼于研究者发起的临床试验，面向未来、引领未来, objectType=article, longId=176061, objectId=61c61e6061dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c61e6061dc, replyNumber=0, likeNumber=65, createdTime=2019-08-04, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c61e6061dc, moduleTitle=CTONG着眼于研究者发起的临床试验，面向未来、引领未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c61e6061dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862780, encodeId=58361862e80ff, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Lentivector基因疗法治疗X连锁严重联合免疫缺陷, objectType=article, longId=168252, objectId=670816825292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=670816825292, replyNumber=0, likeNumber=85, createdTime=2020-04-25, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=670816825292, moduleTitle=Lentivector基因疗法治疗X连锁严重联合免疫缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=670816825292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862785, encodeId=ed501862e855a, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=慢性完全闭塞病变诊治经验：用单指引导管治疗有同侧侧支的CTO病变, objectType=article, longId=178908, objectId=0aab1e890835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aab1e890835, replyNumber=0, likeNumber=70, createdTime=2020-04-09, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aab1e890835, moduleTitle=慢性完全闭塞病变诊治经验：用单指引导管治疗有同侧侧支的CTO病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aab1e890835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862777, encodeId=47721862e77f9, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=DDS：Homoectoine通过阻止上皮紧密连接处的紧密连接开关来预防结肠炎的发生, objectType=article, longId=164737, objectId=4643164e37e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4643164e37e0, replyNumber=0, likeNumber=56, createdTime=2020-02-01, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4643164e37e0, moduleTitle=DDS：Homoectoine通过阻止上皮紧密连接处的紧密连接开关来预防结肠炎的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4643164e37e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862772, encodeId=20551862e72a4, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗, objectType=article, longId=143000, objectId=71c114300015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71c114300015, replyNumber=0, likeNumber=81, createdTime=2018-07-12, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71c114300015, moduleTitle=Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71c114300015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862775, encodeId=98c91862e75b3, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=葛均波院士CTO-AGT（主动迎客技术）正式录用发表, objectType=article, longId=153700, objectId=578e153e000b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=578e153e000b, replyNumber=0, likeNumber=60, createdTime=2019-10-26, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=578e153e000b, moduleTitle=葛均波院士CTO-AGT（主动迎客技术）正式录用发表, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=578e153e000b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862774, encodeId=b2811862e7474, content=<a href='/topic/show?id=0b69542242' target=_blank style='color:#2F92EE;'>#CTO#</a>, objectTitle=一文读懂CTO病变PCI术八种常见并发症, objectType=article, longId=146016, objectId=2b02146016ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b02146016ec, replyNumber=0, likeNumber=64, createdTime=2019-07-17, rootId=0, userName=gao_jian4217, userId=c66088, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b02146016ec, moduleTitle=一文读懂CTO病变PCI术八种常见并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b02146016ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CTO

2020-05-29

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

宋光远：知难而进——CTO开通策略中球囊的应用

2021-07-23

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病

2021-09-18

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

NEJM：Vericiguat能减少心衰高危患者的死亡和住院风险（VICTORIA试验）

2021-01-03

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血

2021-02-07

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Ann Rheum Dis：一种新型可靠的银屑病关节炎指炎整体超声评分(DACTOS)

2020-11-17

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Clinica Chimica Acta：α-Galactosidase / lysoGb3比作为诊断Fabry病女性的一个潜在的标记？

2020-12-26

仁者大医 (审核中...)

前往app查看评论内容

#CTO#

J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果

2019-11-25

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

开启局部晚期肺癌治疗“新模式”——听吴一龙教授解读CTONG1103研究发现

2020-01-07

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

信达生物与Alector合作在中国开发抗肿瘤的SIRP-α单抗

2020-09-10

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

解决复杂CTO难题：IVUS-ATS技术具有重要补充价值

2019-11-29

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

FDA批准Novo Nordisk的Victoza治疗2型糖尿病儿童患者

2019-12-13

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Biofactors：研究发现Zg有益于治疗骨和骨相关疾病

2019-12-12

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

CTOCC 2019｜《冠状动脉慢性完全闭塞病变介入治疗——策略、技术和病例精选》重磅发布

2020-04-14

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

CTONG着眼于研究者发起的临床试验，面向未来、引领未来

2019-08-04

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Lentivector基因疗法治疗X连锁严重联合免疫缺陷

2020-04-25

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

慢性完全闭塞病变诊治经验：用单指引导管治疗有同侧侧支的CTO病变

2020-04-09

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

DDS：Homoectoine通过阻止上皮紧密连接处的紧密连接开关来预防结肠炎的发生

2020-02-01

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗

2018-07-12

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

葛均波院士CTO-AGT（主动迎客技术）正式录用发表

2019-10-26

gao_jian4217 (审核中...)

前往app查看评论内容

#CTO#

一文读懂CTO病变PCI术八种常见并发症

2019-07-17

科室
- - 订阅+
  - 更多科室
工具
服务